Virtual Reality Therapy for Pain Management at the Emergency Department
NCT ID: NCT06089642
Last Updated: 2024-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
124 participants
INTERVENTIONAL
2023-12-01
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Virtual Reality (VR) therapy is a relatively new and promising technique in non-pharmacologic pain reduction and anxiolysis and shows positive results on pain relief and pain.
Objective: Primary objective is to investigate the effect of VR on patient-reported pain outcomes in the ED. Secondary objectives are to investigate the effect of VR on analgesics use, patient-reported outcomes, and process indicators and to identify barriers to implementation. Last, subanalyses will be performed to compare the effectiveness of two types of VR: VR based on distraction (VRD) and VR based on focussed attention (VRF).
Study design: randomized controlled trial.
Study population: Adults admitted to the ED with a NRS pain score of 4 (out of ten) or more and unacceptable pain.
Intervention: There will be a control group receiving usual care and a intervention group that receives additional VR therapy.
Main study parameters/endpoints: The main study outcome is the difference in patient-reported NRS pain score.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality in the Management of Painful or Anxiety-provoking Procedures in Emergency Departments
NCT06425835
The Effect of Virtual Reality on Post-surgical Pain and Recovery.
NCT03933124
Adjunct VR Pain Management in Acute Brain Injury
NCT04356963
Human Factors Analysis in VR for Burn Treatment
NCT00409552
Virtual Reality Analgesia In Trauma Rehab
NCT03894592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Usual care
No interventions assigned to this group
Virtual Reality therapy
Patients receive virtual reality therapy in the form of active distraction or focussed attention (randomized between those two)
Virtual reality
Virtual reality based on distraction and Virtual Reality based on focussed attention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual reality
Virtual reality based on distraction and Virtual Reality based on focussed attention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* NRS pain at rest score ≥4
* Pain not acceptable for patient
* Patient is willing and able to comply with the study protoc
Exclusion Criteria
* EMV \< 14
* History of dementia, seizures
* Severe hearing/visual impairment not corrected
* Headwounds or damaged skin with which comfortable and hygienic use is not possible.
* Presentation to the ED because of chronic pain (≥3 months) exacerbation
* Chronic opioid use (≥3 months)
* Psychiatric disorders interfering with patients' understanding of the study protocol and informed consent
16 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radboud university medical center
Nijmegen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
114609
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.